Clinical Trial Update: A Randomized-Withdrawal Phase 3 Study Evaluating the Safety and Efficacy of Oral Nalfurafine HCl (AC-820)in Subjects on Hemodialysis With Uremic Pruritus (Renal Itch) [Phase 3]

View source ↗

Summary

A Phase 3 randomized-withdrawal trial evaluating the safety and efficacy of oral nalfurafine hydrochloride (AC-820) in subjects on hemodialysis with uremic prur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uremic Pruritus

Drugs mentioned

• Nalfurafine HCl (Nalfurafine hydrochloride)

Snippet

Sponsor: Acologix, Inc. | Conditions: Uremic Pruritus | Phase 3 | Status: UNKNOWN